A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to investigate the blood
glucose lowering effect of NN1250 (insulin degludec) in young and elderly subjects with type
1 diabetes.